Form 13-F position report

BIOANALYTICAL SYSTEMS INC

Reported by Bank of America Corporation

NOTV CUSIP 09058M103 Manager CIK 0000070858

Reported 0 shares, down 52 (100.0%) from the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2020
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 17 Through Q4 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for BIOANALYTICAL SYSTEMS INC held by Bank of America Corporation.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

27 managers reported BIOANALYTICAL SYSTEMS INC for Q4 2020.

Managers reporting BIOANALYTICAL SYSTEMS INC in Q4 2020.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ISZO CAPITAL MANAGEMENT LP New 760,015 +760,015 9.78% $9,348,000 1 qtr
RENAISSANCE TECHNOLOGIES LLC Added 600,065 +100,051 < 0.01% $7,381,000 24 qtrs
VANGUARD GROUP INC Reduced 147,163 -373,030 < 0.01% $1,810,000 31 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 67,510 0 0.02% $830,000 15 qtrs
Private Advisor Group LLC New 64,500 +64,500 < 0.01% $793,000 1 qtr
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM New 51,198 +51,198 < 0.01% $630,000 1 qtr
NEXT CENTURY GROWTH INVESTORS LLC New 43,458 +43,458 0.05% $534,000 1 qtr
BlackRock Inc Reduced 30,701 -21 < 0.01% $377,000 16 qtrs
EAM Investors LLC New 21,958 +21,958 0.04% $270,000 1 qtr
Versant Capital Management Inc Unchanged 19,191 0 0.09% $236,000 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2020
Filed
February 10, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.